We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · June 30, 2021

Cardiovascular Events and Change in Cholesterol Levels in RA Patients Treated With Tocilizumab

Clinical and Experimental Rheumatology


Additional Info

Clinical and Experimental Rheumatology
Cardiovascular Events and Change in Cholesterol Levels in Patients With Rheumatoid Arthritis Treated With Tocilizumab: Data From the REGATE Registry
Clin. Exp. Rheumatol. 2021 May 21;39(3)501-507, C Lukas, M Redondin, I Pane, M Soubrier, E Houvenagel, J Sibilia, B Combe, J Morel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading